Rizzo A.; Mollica V.; Massari F., Re: Hanbing Song, Bobak Seddighzadeh, Matthew R. Cooperberg, Franklin W. Huang. Expression of ACE2 and TMPRSS2, the SARS-CoV-2 Receptor and Co-Receptor, in Prostate Epithelial Cells. Eur Urol. In press DOI: 10.1016/j.eururo.2020.04.065, «JOURNAL OF CLEANER PRODUCTION», 2020, 78, pp. 205 - 206 [articolo]
Rizzo A.; Mollica V.; Massari F., Re: Maha Hussain, Joaquin Mateo, Karim Fizazi, et al. Survival with Olaparib in Metastatic Castration-resistant Prostate Cancer. N Engl J Med. In press. https://doi.org/10.1056/NEJMoa2022485, «EUROPEAN UROLOGY ONCOLOGY», 2020, 3, pp. 806 - 806 [articolo]
Rizzo A.; Mollica V.; Massari F., Re: Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, et al. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.ccr-20-2063, «EUROPEAN UROLOGY ONCOLOGY», 2020, 3, pp. 804 - 805 [articolo]
Massari, F; Mollica, V, Re: Platinum-based Chemotherapy in Metastatic Prostate Cancer with DNA Repair Gene Alterations, «EUROPEAN UROLOGY», 2020, 78, pp. 768 - 770 [articolo]
Mollica V.; Rizzo A.; Massari F., Re: Toni K. Choueiri, Daniel Y.C. Heng, Jae Lyun Lee, et al. Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2020.2218: SAVOIR: From Own Goal to Winning Goal?, «EUROPEAN UROLOGY ONCOLOGY», 2020, 3, pp. 561 - 562 [articolo]
Santoni M.; Heng D.Y.; Bracarda S.; Procopio G.; Milella M.; Porta C.; Matrana M.R.; Carteni G.; Crabb S.J.; De Giorgi U.; Basso U.; Masini C.; Calabro F.; Vitale M.G.; Santini D.; Massari F.; Galli L.; Fornarini G.; Ricotta R.; Buti S.; Zucali P.; Caffo O.; Morelli F.; Carrozza F.; Martignetti A.; Gelibter A.; Iacovelli R.; Mosca A.; Atzori F.; Vau N.; Incorvaia L.; Ortega C.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Paolucci V.; Graham J.; Pierce E.; Scagliarini S.; Sepe P.; Verzoni E.; Merler S.; Rizzo M.; Sorgentoni G.; Conti A.; Piva F.; Cimadamore A.; Montironi R.; Battelli N., Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors, «CANCERS», 2020, 12, Article number: 84, pp. 1 - 13 [articolo]Open Access
Aurilio G.; Santoni M.; Cimadamore A.; Massari F.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Battelli N.; Nole F.; Montironi R., Renal Cell Carcinoma: genomic landscape and clinical implications, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2020, 5, pp. 95 - 100 [articolo]
Loriot, Y.; Sternberg, C. N.; Castellano, D.; Oosting, S. F.; Dumez, H.; Huddart, R.; Vianna, K.; Gordoa, T. A.; Skoneczna, I.; Fay, A. P.; Nole, F.; Massari, F.; Brasiuniene, B.; Maroto, P.; Fear, S.; Di Nucci, F.; de Ducla, S.; Choy, E., Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma, «EUROPEAN JOURNAL OF CANCER», 2020, 138, pp. 202 - 211 [articolo]
Massari F.; Mollica V.; Rizzo A.; Cosmai L.; Rizzo M.; Porta C., Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis, «EXPERT OPINION ON DRUG SAFETY», 2020, 19, pp. 1329 - 1338 [articolo]
Giunchi F.; Franceschini T.; Gruppioni E.; Altimari A.; Capizzi E.; Massari F.; Schiavina R.; Brunelli M.; Martignoni G.; Fiorentino M., Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, «DIAGNOSTICS», 2020, 10, Article number: 123, pp. 123 - 123 [articolo]Open Access
Di Nunno V.; Santoni M.; Mollica V.; Conti A.; Montironi R.; Battelli N.; Ardizzoni A.; Massari F., Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients, «CLINICAL DRUG INVESTIGATION», 2020, 40, pp. 211 - 226 [articolo]
Mollica V.; Rizzo A.; Massari F., The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer, «FUTURE ONCOLOGY», 2020, 16, pp. 2029 - 2033 [articolo]
Cimadamore A.; Aurilio G.; Nole F.; Massari F.; Scarpelli M.; Santoni M.; Lopez-Beltran A.; Cheng L.; Montironi R., Update on circulating tumor cells in genitourinary tumors with focus on prostate cancer, «CELLS», 2020, 9, Article number: 1495, pp. 1 - 18 [articolo]Open Access
Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F, A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss., «MOLECULAR DIAGNOSIS & THERAPY», 2019, 23, pp. 569 - 577 [articolo]
Di Nunno, V.; Mollica, V.; Gatto, L.; Santoni, M.; Sorgentoni, G.; Battelli, N.; Massari, F., Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, pp. 38 - 42 [articolo]
